st 1059 has been researched along with Cirrhosis, Liver in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Ghobashy, MA; Ali, AA; Farid, SF; Kassem, MA | 1 |
| Al-Garem, N; Al-Ghobashy, M; Ali, A; Amin, M; Farid, S; Kassem, M | 1 |
2 other study(ies) available for st 1059 and Cirrhosis, Liver
| Article | Year |
|---|---|
Development and validation of LC-MS/MS assay for the determination of the prodrug Midodrine and its active metabolite Desglymidodrine in plasma of ascitic patients: Application to individualized therapy and comparative pharmacokinetics.
Topics: Adrenergic alpha-1 Receptor Agonists; Ascites; Chromatography, High Pressure Liquid; Drug Monitoring; Humans; Limit of Detection; Liquid-Liquid Extraction; Liver Cirrhosis; Midodrine; Prodrugs; Tandem Mass Spectrometry | 2015 |
Comparative Clinical Pharmacokinetics of Midodrine and Its Active Metabolite Desglymidodrine in Cirrhotic Patients with Tense Ascites Versus Healthy Volunteers.
Topics: Adrenergic alpha-Agonists; Adult; Ascites; Case-Control Studies; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Midodrine; Pilot Projects; Prodrugs; Prospective Studies | 2016 |